Titre:
  • Efficacy and Safety of Switching to Dolutegravir/Lamivudine Fixed-Dose 2-Drug Regimen vs Continuing a Tenofovir Alafenamide-Based 3-or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living with Human Immunodeficiency Virus Type 1: Phase 3, Randomized, Noninferiority TANGO Study
Auteur:Van Wyk, Jean; Ajana, Faïzo; Bisshop, Fiona; De Wit, Stéphane; Osiyemi, Olayemi; Portilla Sogorb, Joaquín; Routy, Jean-Pierre; Wyen, Christoph; Ait-Khaled, Mounir; Nascimento, Maria Claudia; Pappa, Keith; Wang, Ruolan; Wright, Jonathan; Tenorio, Allan A.R.; Wynne, Brian; Aboud, Michael; Gartland, Martin; Smith, Kimberly K.Y.
Informations sur la publication:Clinical infectious diseases, 71, 8, page (1920-1929)
Statut de publication:Publié, 2020-10
Sujet CREF:Pathologie maladies infectieuses
Microbiologie et protistologie [bacteriol.,virolog.,mycolog.]
Microbiologie et protistologie [entomologie,phytoparasitolog.]
Microbiologie et protistologie [parasitologie hum. et anim.]
Mots-clés:2-drug regimen
integrase strand transfer inhibitor
nucleoside reverse transcriptase inhibitor
simplification
virologic suppression
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1058-4838
info:doi/10.1093/cid/ciz1243
info:scp/85086246992
info:pmid/31905383